Stock Weekly: Medicenna Therapeutics (MDNA:CAD5.07) lifts 2.6% on low volume
Dec 11, 2020 - News Bites Canadian Markets
Board and Executive Moves-Event Announcements-Financial Results
CANADIAN WEEKLY STOCK REPORT
Medicenna Therapeutics Corp. (TSX:MDNA), Canada's 13th largest Biotechnology company by market cap, has increased 13.0c (or 2.6%) in the past week to close at CAD5.07. Compared with the S&P/TSX 60 Index which rose 4.1 points (or 0.4%) in the week, this represented a relative price increase of 2.2%.
The price ranged between a low of 4.8 on Wednesday, Dec 09 and a high of 5.03 on Monday, Dec 07. In the past week the market cap has risen by CAD6.4 million (...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
